Orchid sees value pick by Ranbaxy

1,083 views

Published on

Orchid sees value pick by Ranbaxy

Published in: Self Improvement, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,083
On SlideShare
0
From Embeds
0
Number of Embeds
26
Actions
Shares
0
Downloads
25
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Orchid sees value pick by Ranbaxy

  1. 1. Orchid sees value pick by Ranbaxy BS Reporter / Chennai/Tokyo April 11, 2008 Deputy MD says Solrex is linked to Ranbaxy, but stake buy isn� t a takeover attempt. Orchid Chemicals Pharmaceuticals said today that major stakeholder Solrex Pharmaceuticals is linked to Ranbaxy Laboratories, but it did not expect a takeover attempt. Privately held Solrex has acquired an 11.4 per cent stake in Chennai-based Orchid, a bulk drugs and formulations maker, in just two weeks. Orchid shares have doubled in recent weeks amid Solrex's buying and speculation it was linked to Ranbaxy and was preparing a takeover, but they fell 3 per cent to Rs 225.85 on Thursday. Orchid Deputy Managing Director C B Rao told reporters in Tokyo that Solrex is understood to be an investment unit of Ranbaxy, India's biggest drug maker by sales. But I would conclude it is a ...value pick (rather) than a takeover attempt, he said. Shares in Orchid had dropped sharply after Bear Stearns was forced to quick

×